Skip to main content

Lantheus Holdings

Lantheus Holdings Inc is an American radiopharmaceutical company developing and commercializing diagnostic imaging agents and targeted therapeutics. The company provides diagnostic products including Pylarify for prostate cancer imaging, Definity ultrasound contrast agents, and TechneLite radiopharmaceutical generators. Revenue is generated from the sale of radiopharmaceutical diagnostic agents, targeted therapeutics, and specialized radioisotopes to healthcare facilities. Core end markets serve nuclear medicine departments, hospital radiology centers, oncology practices, and cardiology clinics across North America and international markets. Lantheus Holdings holds a market-leading position in nuclear medicine and radiopharmaceutical diagnostic agents in the United States. The company is headquartered in Bedford, Massachusetts, and its common stock trades on the Nasdaq Global Select Market.

10 of the funds FundTelligence covers report a position in Lantheus Holdings.

Legal name
Lantheus Holdings Inc
Sector
Health Care
Country
United States
Funds holding it
10

Funds holding Lantheus Holdings

Showing the 8 largest of 10 funds holding it.

Loading...